Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (2): 173-180.doi: 10.4103/1673-5374.200793

    Next Articles

The promise of stem cell-based therapeutics in ophthalmology

Israel Aharony1, Shalom Michowiz1, 2, Nitza Goldenberg-Cohen1, 3   

  1. 1. The Krieger Eye Research Laboratory, Felsenstein Medical Research Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 
    2. Department of Neurosurgery, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel; 
    3. Department of Ophthalmology, Bnai Zion Medical Center, Haifa, Israel
  • Received:2017-02-06 Online:2017-02-15 Published:2017-02-15
  • Contact: Nitza Goldenberg-Cohen, M.D., ncohen1@gmail.com.
  • Supported by:

    This study was partially supported by the Zanvyl and Isabelle Krieger Fund, Baltimore, Maryland, USA; Israel Scientific Foundation, ISF (1189/12, NGC).

Abstract:

The promising role of cellular therapies in the preservation and restoration of visual function has prompted intensive efforts to characterize embryonic, adult, and induced pluripotent stem cells for regenerative purposes. Three main approaches to the use of stem cells have been described: sustained drug delivery, immunomodulation, and differentiation into various ocular structures. Studies of the differentiation capacity of all three types of stem cells into epithelial, neural, glial and vascular phenotypes have reached proof-of-concept in culture, but the correction of vision is still in the early developmental stages, and the requirements for effective in vivo implementation are still unclear. We present an overview of some of the preclinical findings on stem-cell rescue and regeneration of the cornea and retina in acute injury and degenerative disorders.

Key words: embryonic stem cells, adult stem cells, induced pluripotent stem cells, cornea, retina, neuroprotection, immunomodulation, tissue recovery, regeneration, acute ocular injury, degenerative retinal disorders